+1 858-523-8231
Login | Register
menu
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
882847-34-9,MFCD06656474
Catalog No.:AA0049FO

882847-34-9 | Fmoc-N-amido-PEG6-acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
95%
in stock  
$67.00   $47.00
- +
25g
97%
in stock  
$1,640.00 $1,148.00
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA0049FO
Chemical Name:
Fmoc-N-amido-PEG6-acid
CAS Number:
882847-34-9
Molecular Formula:
C30H41NO10
Molecular Weight:
575.6472
MDL Number:
MFCD06656474
SMILES:
OC(=O)CCOCCOCCOCCOCCOCCOCCNC(=O)OCC1c2ccccc2c2c1cccc2
Properties
Properties
 
BP:
734.8±60.0°C at 760 mmHg  
Form:
Liquid  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
689  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
41  
Hydrogen Bond Acceptor Count:
10  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
24  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
1.7  

Downstream Synthesis Route
882847-34-9   
C40H48F3N10O9Pol 
 
C70H87F3N11O18Pol 

[1]CurrentPatentAssignee:PURDUEUNIVERSITYSYSTEM-WO2008/98112,2008,A2Locationinpatent:Page/Pagecolumn32

[1]Sundgren,Andreas;BarchiJr.,JosephJ.[CarbohydrateResearch,2008,vol.343,#10-11,p.1594-1604]

882847-34-9   
C25H49N2O3Pol 
 
C55H88N3O12Pol 

[1]Kashiwada,Ayumi;Tsuboi,Mana;Matsuda,Kiyomi[ChemicalCommunications,2009,#6,p.695-697]

[1]HelveticaChimicaActa,2009,vol.92,p.2698-2721

193475-66-0    882847-34-9   
N-Fmoc-Tyr-OH 
 
N-α-9-fluorenylmethoxycarbonyl-asparticacid 
 
(S)-2-{({9H-fluoren-9-yl}methoxy)carbonyl}aminopentanedioicacid 
  108-24-7   
9-fluorenylmethoxycarbonyl-L-alaninehydrochloride 
 
C83H118N16O40S 

[1]Kitamatsu,Mizuki;Futami,Midori;Sisido,Masahiko[ChemicalCommunications,2010,vol.46,#5,p.761-763]

Literature

Title: Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent.

Journal: International journal of nanomedicine 20120101

Title: ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
Submit
SDS
Related Products of 882847-34-9
117106-20-4

117106-20-4

 146346-88-5

146346-88-5

 159610-93-2

159610-93-2

 1654740-73-4

1654740-73-4

 166108-71-0

166108-71-0

 204320-51-4

204320-51-4
Building Blocks
More >
Tags:882847-34-9 Molecular Formula|882847-34-9 MDL|882847-34-9 SMILES|882847-34-9 Fmoc-N-amido-PEG6-acid
Catalog No.: AA0049FO
882847-34-9,MFCD06656474
882847-34-9 | Fmoc-N-amido-PEG6-acid
Pack Size： 1g
Purity： 95%
in stock
$67.00 $47.00
Pack Size： 25g
Purity： 97%
in stock
$1,640.00 $1,148.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA0049FO
Chemical Name: Fmoc-N-amido-PEG6-acid
CAS Number: 882847-34-9
Molecular Formula: C30H41NO10
Molecular Weight: 575.6472
MDL Number: MFCD06656474
SMILES: OC(=O)CCOCCOCCOCCOCCOCCOCCNC(=O)OCC1c2ccccc2c2c1cccc2
Properties
BP: 734.8±60.0°C at 760 mmHg  
Form: Liquid  
Storage: Keep in dry area;2-8℃;  
Complexity: 689  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 41  
Hydrogen Bond Acceptor Count: 10  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 24  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: 1.7  
Downstream Synthesis Route
882847-34-9   
C40H48F3N10O9Pol 
 
C70H87F3N11O18Pol 

[1]CurrentPatentAssignee:PURDUEUNIVERSITYSYSTEM-WO2008/98112,2008,A2Locationinpatent:Page/Pagecolumn32

882847-34-9    6456-74-2    1040395-79-6 

[1]Sundgren,Andreas;BarchiJr.,JosephJ.[CarbohydrateResearch,2008,vol.343,#10-11,p.1594-1604]

882847-34-9   
C25H49N2O3Pol 
 
C55H88N3O12Pol 

[1]Kashiwada,Ayumi;Tsuboi,Mana;Matsuda,Kiyomi[ChemicalCommunications,2009,#6,p.695-697]

882847-34-9    172695-33-9    193954-26-6    193954-27-7    203854-51-7    203854-47-1    219967-69-8    1207335-59-8 

[1]HelveticaChimicaActa,2009,vol.92,p.2698-2721

193475-66-0    882847-34-9   
N-Fmoc-Tyr-OH 
 
N-α-9-fluorenylmethoxycarbonyl-asparticacid 
 
(S)-2-{({9H-fluoren-9-yl}methoxy)carbonyl}aminopentanedioicacid 
  108-24-7   
9-fluorenylmethoxycarbonyl-L-alaninehydrochloride 
 
C83H118N16O40S 

[1]Kitamatsu,Mizuki;Futami,Midori;Sisido,Masahiko[ChemicalCommunications,2010,vol.46,#5,p.761-763]

Literature fold

Title: Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agent.

Journal: International journal of nanomedicine20120101

Title: ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.

Related Products of of 882847-34-9
117106-20-4
117106-20-4
146346-88-5
146346-88-5
159610-93-2
159610-93-2
1654740-73-4
1654740-73-4
166108-71-0
166108-71-0
204320-51-4
204320-51-4
Building Blocks More >
88877-00-3
88877-00-3
5-Acetyl-6-(2-(dimethylamino)vinyl)pyridin-2(1H)-one
AA004ADR | MFCD01814813
88203-19-4
88203-19-4
4-Chloro-2-chloromethyl-5,6-dimethyl-thieno[2,3-d]pyrimidine
AA004C4W | MFCD06656974
87932-49-8
87932-49-8
3-Chloro-4,5-dihydroxybenzoic acid
AA004DKV | MFCD01742816
88179-71-9
88179-71-9
Chola-4,6-dien-24-oicacid, 3-oxo-
AA004ESW | MFCD00200652
87864-20-8
87864-20-8
PPHP
AA004G31 | MFCD00216135
876716-58-4
876716-58-4
2-(3,5-Dimethylpiperidin-1-yl)ethanamine
AA004H3E | MFCD06740357
868770-14-3
868770-14-3
(4-Benzyl-morpholin-2-ylmethyl)-ethyl-amine
AA004I9D | MFCD06658341
872183-39-6
872183-39-6
3-Allyl-5-methoxy-4-(prop-2-yn-1-yloxy)benzaldehyde
AA004JBG | MFCD02629580
87015-91-6
87015-91-6
2-(4-(tert-Butyl)benzamido)acetic acid
AA004K7G | MFCD00020448
86604-40-2
86604-40-2
2-Amino-4-(4-methoxyphenyl)-3-thiophenecarbonitrile
AA004KZG | MFCD02854973
Submit
© 2017 AA BLOCKS, INC. All rights reserved.